 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Corvus Pharmaceuticals Inc. (CRVS)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-06-27 Purchase | 2019-07-01 6:15 pm | Corvus Pharmaceuticals Inc. | CRVS | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC Director 10% Owner | 657,344 | $3.7181 | $2,444,065 | 6,624,928 (Indirect) | View |
| 2019-06-27 Purchase | 2019-07-01 6:16 pm | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 657,344 | $3.7181 | $2,444,065 | 6,624,928 (Indirect) | View |
| 2019-07-23 Sale | 2019-07-25 7:21 pm | Corvus Pharmaceuticals Inc. | CRVS | Novo Holdings A/S 10% Owner | 1,492,956 | $4.071 | $6,077,845 | 2,927,560 (Direct) | View |
| 2019-08-06 Purchase | 2019-08-08 4:07 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 7,500 | $3.5633 | $26,725 | 1,163,507 (Indirect) | View |
| 2019-08-06 Purchase | 2019-08-08 4:59 pm | Corvus Pharmaceuticals Inc. | CRVS | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC Director 10% Owner | 142,656 | $3.51 | $500,723 | 6,767,584 (Indirect) | View |
| 2019-08-06 Purchase | 2019-08-08 5:00 pm | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 142,656 | $3.51 | $500,723 | 6,767,584 (Indirect) | View |
| 2019-11-12 Purchase | 2019-11-14 4:14 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 15,008 | $3.0003 | $45,029 | 1,178,515 (Indirect) | View |
| 2020-07-07 Sale | 2020-07-09 4:35 pm | Corvus Pharmaceuticals Inc. | CRVS | Novo Holdings A/S 10% Owner | 1,538,062 | $5.3109 | $8,168,547 | 1,389,498 (Direct) | View |
| 2021-02-17 Purchase | 2021-02-17 4:44 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 100,000 | $3.5 | $350,000 | 1,278,515 (Indirect) | View |
| 2021-02-17 Purchase | 2021-02-19 4:47 pm | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 1,285,714 | $3.5 | $4,499,999 | 8,053,298 (Indirect) | View |
| 2021-02-17 Purchase | 2021-02-19 4:52 pm | Corvus Pharmaceuticals Inc. | CRVS | ORBIMED ADVISORS LLC OrbiMed Capital GP V LLC Director 10% Owner | 1,285,714 | $3.5 | $4,499,999 | 8,053,298 (Indirect) | View |
| 2021-05-04 Purchase | 2021-05-05 5:01 pm | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 35,714 | $2.8 | $99,999 | 35,714 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-06-20 Option Award | 2019-06-24 4:07 pm | N/A 2029-06-20 | Corvus Pharmaceuticals Inc. | CRVS | Krognes Steve E. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2019-06-20 Option Award | 2019-06-24 4:09 pm | N/A 2029-06-20 | Corvus Pharmaceuticals Inc. | CRVS | ADAMS STREET PARTNERS LLC 10% Owner | 15,000 | $0 | 15,000 (Indirect) | View |
| 2019-12-12 Option Award | 2019-12-16 4:11 pm | N/A 2029-12-12 | Corvus Pharmaceuticals Inc. | CRVS | Buggy Joseph J VP | 40,000 | $0 | 40,000 (Direct) | View |
| 2019-12-12 Option Award | 2019-12-16 4:11 pm | N/A 2029-12-12 | Corvus Pharmaceuticals Inc. | CRVS | Hunt Daniel W. SVP Chief Business Officer | 75,000 | $0 | 75,000 (Direct) | View |
| 2019-12-12 Option Award | 2019-12-16 4:12 pm | N/A 2029-12-12 | Corvus Pharmaceuticals Inc. | CRVS | Jones William Benton See Remarks | 160,000 | $0 | 160,000 (Direct) | View |
| 2019-12-12 Option Award | 2019-12-16 4:13 pm | N/A 2029-12-12 | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV CFO | 160,000 | $0 | 160,000 (Direct) | View |
| 2019-12-12 Option Award | 2019-12-16 4:14 pm | N/A 2029-12-12 | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 320,000 | $0 | 320,000 (Direct) | View |
| 2019-12-12 Option Award | 2019-12-16 4:15 pm | N/A 2029-12-12 | Corvus Pharmaceuticals Inc. | CRVS | Mobasher Mehrdad VP Chief Medical Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2019-12-12 Option Award | 2019-12-16 4:16 pm | N/A 2029-12-12 | Corvus Pharmaceuticals Inc. | CRVS | Verner Erik J. VP | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 4:03 pm | N/A 2030-03-19 | Corvus Pharmaceuticals Inc. | CRVS | ADAMS STREET PARTNERS LLC 10% Owner | 15,000 | $0 | 15,000 (Indirect) | View |
| 2020-03-19 Option Award | 2020-03-23 5:27 pm | N/A 2030-03-19 | Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 5:28 pm | N/A 2030-03-19 | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 5:29 pm | N/A 2030-03-19 | Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 5:29 pm | N/A 2030-03-19 | Corvus Pharmaceuticals Inc. | CRVS | Krognes Steve E. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 5:30 pm | N/A 2030-03-19 | Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-03-19 Option Award | 2020-03-23 5:31 pm | N/A 2030-03-19 | Corvus Pharmaceuticals Inc. | CRVS | Grais Linda S Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-12 5:07 pm | N/A 2030-06-09 | Corvus Pharmaceuticals Inc. | CRVS | CLARK IAN T Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-12 5:10 pm | N/A 2030-06-09 | Corvus Pharmaceuticals Inc. | CRVS | Grais Linda S Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-12 5:11 pm | N/A 2030-06-09 | Corvus Pharmaceuticals Inc. | CRVS | Gould Terry P Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-12 5:13 pm | N/A 2030-06-09 | Corvus Pharmaceuticals Inc. | CRVS | Krognes Steve E. Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-12 5:14 pm | N/A 2030-06-09 | Corvus Pharmaceuticals Inc. | CRVS | Morrison Scott W Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-12 5:15 pm | N/A 2030-06-09 | Corvus Pharmaceuticals Inc. | CRVS | Thompson Peter A. Director 10% Owner | 15,000 | $0 | 15,000 (Direct) | View |
| 2020-06-09 Option Award | 2020-06-15 5:28 pm | N/A 2030-06-09 | Corvus Pharmaceuticals Inc. | CRVS | ADAMS STREET PARTNERS LLC 10% Owner | 15,000 | $0 | 15,000 (Indirect) | View |
| 2020-09-10 Option Award | 2020-09-15 5:05 pm | N/A 2030-09-10 | Corvus Pharmaceuticals Inc. | CRVS | Mitchell Edith P. Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-17 4:15 pm | N/A 2030-12-16 | Corvus Pharmaceuticals Inc. | CRVS | Mobasher Mehrdad SVP Chief Medical Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-17 4:16 pm | N/A 2030-12-16 | Corvus Pharmaceuticals Inc. | CRVS | MILLER RICHARD A MD CEO | 320,000 | $0 | 320,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-17 4:17 pm | N/A 2030-12-16 | Corvus Pharmaceuticals Inc. | CRVS | LEA LEIV CFO | 160,000 | $0 | 160,000 (Direct) | View |
| 2020-12-16 Option Award | 2020-12-17 4:17 pm | N/A 2030-12-16 | Corvus Pharmaceuticals Inc. | CRVS | Jones William Benton See Remarks | 160,000 | $0 | 160,000 (Direct) | View |